Christine Posted September 4, 2007 Share Posted September 4, 2007 PARIS, Sep. 4, 2007 -- Pharmaceutical company Sanofi-Aventis said seven trials of its Taxotere drug in treating non-small cell lung cancer showed a 'significant' improvement in overall survival rates versus existing treatments. Taxotere, an anti-cancer agent used in other treatments, is the company's fourth best-selling drug. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.